EA201290772A1 - Новые формы ивабрадина гидрохлорида - Google Patents
Новые формы ивабрадина гидрохлоридаInfo
- Publication number
- EA201290772A1 EA201290772A1 EA201290772A EA201290772A EA201290772A1 EA 201290772 A1 EA201290772 A1 EA 201290772A1 EA 201290772 A EA201290772 A EA 201290772A EA 201290772 A EA201290772 A EA 201290772A EA 201290772 A1 EA201290772 A1 EA 201290772A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- new forms
- hydrochloride
- ivabradin
- ivabradin hydrochloride
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Настоящее изобретение относится к новым кристаллическим формам ивабрадина гидрохлорида и фармацевтическим композициям, полученным из них.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI201000057 | 2010-02-12 | ||
PCT/EP2011/052068 WO2011098582A2 (en) | 2010-02-12 | 2011-02-11 | Novel forms of ivabradine hydrochloride |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201290772A1 true EA201290772A1 (ru) | 2013-02-28 |
Family
ID=43770633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201290772A EA201290772A1 (ru) | 2010-02-12 | 2011-02-11 | Новые формы ивабрадина гидрохлорида |
Country Status (6)
Country | Link |
---|---|
EP (2) | EP2534135A2 (ru) |
EA (1) | EA201290772A1 (ru) |
HU (1) | HUE035588T2 (ru) |
PL (1) | PL2902384T3 (ru) |
SI (2) | SI23290A (ru) |
WO (1) | WO2011098582A2 (ru) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130084335A1 (en) | 2010-06-14 | 2013-04-04 | Ratiopharm Gmbh | Ivabradine-containing pharmaceutical composition |
WO2012025940A1 (en) * | 2010-08-25 | 2012-03-01 | Cadila Healthcare Limited | Polymorphic form of ivabradine hydrochloride and process for preparation thereof |
JP2014521714A (ja) | 2011-08-12 | 2014-08-28 | ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネコ科動物の心不全を治療および予防する方法において使用するための奇異性電流(If)阻害薬 |
EP2589594A1 (en) | 2011-11-04 | 2013-05-08 | Urquima S.A. | Ivabradine hydrochloride Form IV |
EP3156399A1 (en) | 2011-11-14 | 2017-04-19 | Cadila Healthcare Limited | Polymorphic forms of ivabradine hydrochloride |
IN2012CH01309A (ru) * | 2012-04-02 | 2015-06-19 | Hetero Research Foundation | |
WO2014024210A2 (en) * | 2012-08-10 | 2014-02-13 | Hetero Research Foundation | Novel polymorphs of doxercalciferol |
WO2014122248A1 (en) | 2013-02-11 | 2014-08-14 | Boehringer Ingelheim Vetmedica Gmbh | Kit-of-parts |
ITMI20130416A1 (it) * | 2013-03-19 | 2014-09-20 | Chemo Res S L | Nuovo polimorfo del cloridrato di ivabradina e metodo per la sua preparazione |
ES2773502T5 (es) | 2013-03-19 | 2023-11-30 | Chemo Res S L | Nuevo polimorfo de clorhidrato de ivabradina y método para su preparación |
WO2015001569A1 (en) * | 2013-07-02 | 2015-01-08 | Genepharm India Private Limited | A solid pharmaceutical composition of ivabradine for oral administration |
CZ2013767A3 (cs) | 2013-10-02 | 2015-04-29 | Zentiva, K.S. | Pevná forma Ivabradin hydrochloridu a (S)-mandlové kyseliny a její farmaceutická kompozice |
MX363389B (es) | 2013-12-12 | 2019-03-20 | Synthon Bv | Composicion farmaceutica que comprende ivabradina amorfa. |
EP3082772A1 (en) * | 2013-12-20 | 2016-10-26 | Synhton B.V. | Pharmaceutical composition comprising amorphous ivabradine |
EP2774606B1 (en) * | 2014-02-14 | 2019-01-30 | Synthon B.V. | Pharmaceutical composition comprising ivabradine hydrochloride polymorph IV |
EP3122362A1 (en) * | 2014-03-27 | 2017-02-01 | Laboratorio Chimico Internazionale S.p.A. | Ivabradine adsorbates |
CZ305436B6 (cs) | 2014-07-10 | 2015-09-16 | Zentiva, K.S. | Pevná forma Ivabradin hydrochloridu a (R)-mandlové kyseliny a její farmaceutická kompozice |
EP3366282A1 (en) * | 2017-02-28 | 2018-08-29 | Sanovel Ilac Sanayi ve Ticaret A.S. | Solid oral pharmaceutical compositions of ivabradine |
TR201703066A2 (tr) * | 2017-02-28 | 2018-09-21 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | İvabradi̇ni̇n kati oral farmasöti̇k kompozi̇syonlari |
IT202000025312A1 (it) | 2020-10-26 | 2022-04-26 | Cambrex Profarmaco Milano S R L | Processi per la preparazione di polimorfi di ivabradina hcl |
WO2023094048A1 (en) * | 2021-11-24 | 2023-06-01 | Nutrition & Biosciences Usa 1, Llc | Process for producing microcrystalline cellulose with reduced nitrite salt content |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2681862B1 (fr) | 1991-09-27 | 1993-11-12 | Adir Cie | Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent. |
FR2868775B1 (fr) | 2004-04-13 | 2008-04-11 | Servier Lab | Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
FR2868776B1 (fr) | 2004-04-13 | 2008-04-18 | Servier Lab | Nouveau procede de synthese de derives de la 1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
FR2868777B1 (fr) | 2004-04-13 | 2006-05-26 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
FR2870537A1 (fr) | 2004-05-19 | 2005-11-25 | Servier Lab | Nouveau procede de synthese du (1s)-4,5-dimethoxy-1-(methyl aminomethyl-)-benzocyclobutane et de ses sels d'addition, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
FR2882556B1 (fr) * | 2005-02-28 | 2007-05-04 | Servier Lab | Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
FR2882553B1 (fr) * | 2005-02-28 | 2007-05-04 | Servier Lab | Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
FR2882555B1 (fr) * | 2005-02-28 | 2007-05-04 | Servier Lab | Forme cristalline gamma du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
FR2882554B1 (fr) * | 2005-02-28 | 2007-05-04 | Servier Lab | Forme critalline beta d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
FR2891827B1 (fr) * | 2005-10-11 | 2007-12-28 | Servier Lab | Forme cristalline deltad du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
FR2891826B1 (fr) * | 2005-10-11 | 2007-12-28 | Servier Lab | Forme cristalline 6 du chlorhydrate de l'ivabradine, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
ES2381771T3 (es) | 2006-11-30 | 2012-05-31 | Cadila Healthcare Limited | Procedimiento para la preparación de hidrocloruro de ivabradina |
WO2008125006A1 (fr) | 2007-04-12 | 2008-10-23 | Utopharm (Shanghai) Co., Ltd | Procédés de préparation du chlorhydrate d'ivabradine et de sa forme cristalline stable |
EP2162438A4 (en) | 2007-05-30 | 2011-07-06 | Ind Swift Lab Ltd | PROCESS FOR THE PREPARATION OF IVABRADINE HYDROCHLORIDE AND CORRESPONDING POLYMORPHIDE |
CN101434552B (zh) | 2007-11-16 | 2012-05-23 | 江苏恒瑞医药股份有限公司 | 4,5-二甲氧基-1-(甲基氨基甲基)-苯并环丁烷的拆分 |
CN101544605A (zh) | 2008-03-24 | 2009-09-30 | 北京深蓝海生物医药科技有限公司 | 伊伐布雷定及其药学上可接受的加成盐的制备方法 |
CN101343249A (zh) | 2008-06-10 | 2009-01-14 | 上海医药工业研究院 | 3-(3-氯丙基)-7,8-二甲氧基-1,3-二氢-2h-3-苯并氮杂-2-酮的制备方法 |
FR2932800B1 (fr) | 2008-06-20 | 2015-02-20 | Servier Lab | Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
FR2933975B1 (fr) | 2008-07-17 | 2011-02-18 | Servier Lab | Nouveau procede de preparation de benzocyclobutenes fonctionnalises,et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable. |
-
2011
- 2011-02-11 EA EA201290772A patent/EA201290772A1/ru unknown
- 2011-02-11 HU HUE15151073A patent/HUE035588T2/en unknown
- 2011-02-11 EP EP11702672A patent/EP2534135A2/en not_active Withdrawn
- 2011-02-11 WO PCT/EP2011/052068 patent/WO2011098582A2/en active Application Filing
- 2011-02-11 EP EP15151073.2A patent/EP2902384B1/en active Active
- 2011-02-11 PL PL15151073T patent/PL2902384T3/pl unknown
- 2011-02-11 SI SI201100042A patent/SI23290A/sl not_active IP Right Cessation
- 2011-02-11 SI SI201131384T patent/SI2902384T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2011098582A2 (en) | 2011-08-18 |
EP2902384B1 (en) | 2017-11-08 |
SI2902384T1 (en) | 2018-03-30 |
EP2534135A2 (en) | 2012-12-19 |
WO2011098582A3 (en) | 2012-03-01 |
EP2902384A1 (en) | 2015-08-05 |
SI23290A (sl) | 2011-08-31 |
HUE035588T2 (en) | 2018-05-28 |
PL2902384T3 (pl) | 2018-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201290772A1 (ru) | Новые формы ивабрадина гидрохлорида | |
JOP20180103B1 (ar) | التركيب الصيدلاني للكاربيتوسين | |
EA201171151A1 (ru) | Кристаллические трипептидные ингибиторы эпоксикетон-протеазы | |
EA201170396A1 (ru) | 2-оксо-1,2-дигидрохинолиновые модуляторы иммунной функции | |
PH12014502697A1 (en) | New diazaspirocycloalkane and azaspirocycloalkane | |
MY181898A (en) | Heterocyclic compounds and uses thereof | |
EA201391318A1 (ru) | Твердые формы 3-(5-амино-2-метил-4-оксо-4н-хиназолин-3-ил)пиперидин-2,6-диона и их фармацевтические композиции и применение | |
EA201490806A1 (ru) | Комбинированный состав двух противовирусных соединений | |
EA201590534A1 (ru) | Новые бициклические производные | |
EA201490567A1 (ru) | Новые бициклические производные дигидрохинолин-2-она | |
EA201300388A1 (ru) | Соединения замещенного бензамида | |
UA113062C2 (xx) | Похідні 5-фтор-4-іміно-3-(заміщеного)-3,4-дигідропіримідин-2(1h)ону | |
EA201590887A1 (ru) | Композиция | |
EA201490037A1 (ru) | Антагонисты trpv4 | |
EA201500628A1 (ru) | Индолкарбоксамидные производные в качестве антагонистов p2xрецепторов | |
MA34075B1 (fr) | Composition pharmaceutique comprenant un dérivé pyrimidineone | |
EA200971140A1 (ru) | Триарильные соединения и композиции, их содержащие | |
EA201490846A1 (ru) | Новые производные арилхинолина | |
EA201300034A1 (ru) | Фармацевтические композиции, содержащие иматиниб или его фармацевтически приемлемую соль, и способы их получения | |
EA201490756A1 (ru) | Разагилина цитрамид | |
EA201290642A1 (ru) | Соединения и способы | |
EA201490761A1 (ru) | R(+)-n-формилпропаргиламиноиндан | |
EA201270256A1 (ru) | Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида | |
EA201400822A1 (ru) | Производные гетероциклических амидов в качестве антагонистов p2xрецептора | |
EA201001353A1 (ru) | Гидробромид ивабрадина |